The all-cause mortality, vascular death and stroke do not differ, but the risk of myocardial infarction is marginally lower (the number needed to treat is 244) in patients receiving P2Y12 inhibitor compared with those receiving aspirin [69]. Here, P2RY12 is linked to Stroke.